Therapanacea - FloodGate Medical

Reinventing Cancer Care through AI

About Us

At TheraPanacea, an award-winning medical technology company created in 2017, we are harnessing AI to develop cutting-edge software for more efficient and precise cancer care. We offer pioneering holistic approaches for cancer research and treatment based on a multi-scale integration of medicine, information theory, data curation and computational medicine.

A vastly experienced team, we are devoted to unlock the unlimited power of AI-based software to drive innovation in healthcare. Endowed with an excellent IP portfolio, our vision is to exploit state-of-the-art research technology to accelerate health care’s transition towards predictive, evidence-driven, adaptive treatment planning and delivery.

Look at the Leaders of TheraPanacea

Nikos Paragios

Chief Executive Officer

Catherine Martineau-Huynh

Chief Operating Officer & Cofounder

Alexandre Favre

Chief Financial Officer

Featured Services and Innovations

ART-Plan™

ART-Plan™ by TheraPanacea is a fully AI-driven, web-based radiotherapy planning platform—CE-marked and FDA-cleared—designed to dramatically accelerate and standardize contouring, image registration, synthetic CT generation, and adaptive treatment assessment for cancer care. With zero-click delineation of over 200 organs-at-risk and lymph nodes, seamless multimodal image fusion, and pseudo-CT generation from MR or CBCT, ART-Plan delivers expert-level contours in minutes, saving up to 90% of manual effort and empowering clinicians to deliver more precise, efficient, and scalable treatment workflows.

Company Spotlight Video

News and Stories

Our scientific work at ESTRO 2025

May 5, 2025 — We’re excited to announce that 13 abstracts have been accepted at ESTRO this year. We are deeply grateful for the outstanding collaborations with our clinical and academic partners, whose contributions are instrumental in advancing the integration of AI into Radiotherapy workflows.

Unlocking the Potential of AI Auto-Contouring in Radiotherapy at HELSE Bergen [WEBINAR]

June 25, 2024 — Dive into the transformative journey of artificial intelligence in clinical practice and see how it’s reshaping the landscape of radiotherapy!

In this insightful session from the Human Bytes Academy, Lukas Hirschi from Haukeland University Hospital HELSE Bergen shared his extensive experience with AI-powered auto-contouring tool. He discusses its procurement, implementation/clinical application, and how their team has led a pioneering study to support its use.

Learn more about valuable insights on how AI can enhance a radiation oncology department workflow and optimize the patients’ treatment planning!

Our scientific work at ESTRO 2024

Exciting Milestones in Precision Radiotherapy (PRT)

April 30, 2024 — Our precision radiotherapy (PRT) endeavors have achieved remarkable progress, with 16 accepted abstracts at ESTRO this year, surpassing last year’s count of 13. Collaborating with esteemed clinical and academic partners, these insights hold the potential to revolutionize radiotherapy (RT) workflows. Our focus areas include automated treatment planning, vendor-agnostic adaptive radiation therapy, magnetic resonance-only RT planning, and uncertainty-aware automatic delineation of tumors and organs at risk, guided by consensus protocols.

Looking to stand out from the crowd during your job search? Click below to gain access to our top tips & tools for candidates during the hiring process!

Recruiting Done Differently.

Improving lives by uniting great people with great companies.

Sign up for our Monthly Newsletter

We’re committed to sharing up-to-date industry insights, our newest career opportunities, and valuable tools to support you throughout your next job search. Let’s stay connected!